Digestive & Intestinal Remedies (Pharmacies) - Pakistan

Revenue in the Digestives & Intestinal Remedies market is projected to reach US$57.01m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 4.64%, resulting in a market volume of US$71.53m by 2029.
In global comparison, most revenue will be generated China (US$3.37bn in 2024).
In relation to total population figures, per person revenues of US$0.23 are generated in 2024.

Definition:
The Digestives and Intestinal Remedies market encompasses a range of over-the-counter (OTC) natural and synthetic digestive agents and remedies designed to address gastrointestinal concerns. These products are available through pharmacies and are provided in various forms such as pills, powder, capsules, liquids, solutions, suspensions, drops, and suppositories. The market excludes prescription medications, substances contravening state regulations, or items not explicitly categorized as digestive medications (e.g., pain relievers). Notable among the best-selling products in this category are Perenterol, Iberogast, Dulcolax, and Buscopan Plus. This market exclusively covers product sales through pharmacies.

Additional information:
The Digestives and Intestinal Remedies market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
Digestive medicines
Remedies against gastrointestinal complaints

Prescription medicines
Homeopathic remedies
Tea

The Digestive & Intestinal Remedies (Pharmacies) market in Pakistan is experiencing steady growth and development.

Customer preferences: In Pakistan, there is a growing demand for digestive and intestinal remedies in pharmacies. This can be attributed to several factors. Firstly, the increasing prevalence of digestive and intestinal issues among the population has led to a greater need for these remedies. This can be attributed to changing dietary patterns, sedentary lifestyles, and the consumption of unhealthy food. Secondly, there is a growing awareness among consumers about the importance of maintaining good digestive health, leading to a higher demand for remedies that can help alleviate symptoms and promote overall digestive wellness.

Trends in the market: One of the key trends in the Digestive & Intestinal Remedies market in Pakistan is the shift towards natural and herbal remedies. Consumers are becoming more conscious about the potential side effects of synthetic medications and are seeking natural alternatives. This has led to an increase in the demand for herbal remedies that are perceived to be safer and more gentle on the digestive system. Additionally, there is a growing trend towards combination products that offer multiple benefits, such as remedies that address both digestive and immune health.

Local special circumstances: Pakistan has a large population with a high prevalence of digestive and intestinal issues. This can be attributed to factors such as poor sanitation, lack of access to clean drinking water, and inadequate healthcare facilities in certain areas. As a result, there is a greater need for digestive and intestinal remedies in the country. Furthermore, the traditional diet in Pakistan is rich in spices and heavy foods, which can contribute to digestive problems. This cultural aspect also influences the demand for remedies in the market.

Underlying macroeconomic factors: The growing middle class in Pakistan is a key driver of the Digestive & Intestinal Remedies market. As disposable incomes increase, consumers have more purchasing power to spend on healthcare products, including remedies for digestive and intestinal issues. Additionally, the expanding pharmaceutical industry in Pakistan is contributing to the availability and accessibility of these remedies. The government's focus on improving healthcare infrastructure and increasing healthcare expenditure is also expected to drive the growth of the market. In conclusion, the Digestive & Intestinal Remedies market in Pakistan is growing due to increasing customer preferences for natural and herbal remedies, a high prevalence of digestive and intestinal issues, and underlying macroeconomic factors such as a growing middle class and government initiatives to improve healthcare infrastructure.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.